Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.619, 2011-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Adalimumab/infliximab: Psoriasis: case report
Reactions Weekly, Vol. 1, Iss. 1350, 2011-01 ,pp. :
Access to resources
Recommend
Adalimumab improves symptoms and QOL in rheumatoid arthritis
Inpharma, Vol. 1, Iss. 1367, 2002-01 ,pp. :
Meaningful QOL gains with alosetron in women with IBS-D
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 660, 2012-01 ,pp. :
Adalimumab GAINs more CHARM in Crohn's disease
Inpharma, Vol. 1, Iss. 1567, 2006-01 ,pp. :
Adalimumab/etanercept/infliximab: Psoriasis (first report with adalimumab): 5 case reports
Reactions Weekly, Vol. 1, Iss. 1075, 2005-01 ,pp. :